Roger S. Newton
2013
In 2013, Roger S. Newton earned a total compensation of $1.8M as Executive Chairman and Chief Scientific Officer at Esperion Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $1,304,635 |
| Salary | $375,000 |
| Total | $1,829,635 |
Newton received $1.3M in option awards, accounting for 71% of the total pay in 2013.
Newton also received $150K in non-equity incentive plan and $375K in salary.
Rankings
In 2013, Roger S. Newton's compensation ranked 4,185th out of 12,286 executives tracked by ExecPay. In other words, Newton earned more than 65.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,185 out of 12,286 | 66th |
Division Manufacturing | 1,435 out of 4,612 | 69th |
Major group Chemicals And Allied Products | 392 out of 1,462 | 73rd |
Industry group Drugs | 272 out of 1,156 | 77th |
Industry Pharmaceutical Preparations | 221 out of 890 | 75th |
Source: SEC filing on April 28, 2016.
Newton's colleagues
We found one more compensation record of an executive who worked with Roger S. Newton at Esperion Therapeutics in 2013.
2013
Tim Mayleben
Esperion Therapeutics